Disinfectant to revolutionise fight against Covid-19 in care home sector
20 August, 2020
The hygiene product manufacturer, Aqualution Systems, is working with the care home sector to deploy its, anti-virus, infection control, ‘Salvesan’ brand of hypochlorous acid (HOCl), disinfectant which kills 99.99% of viruses and 99.9999% of bacteria in seconds.
HOCl is gaining more and more attention as various sectors begin to understand its revolutionary properties and their role in fighting the COVID-19 virus. HOCl occurs naturally in the human body and when manufactured for use in infection control regimes, is completely non-toxic for humans, animals and plants, and is environmentally-friendly too.
Aqualution Systems chief executive Nick Meakin said: “Our product application system and regime is providing healthcare facilities with the best probability of protecting against infection and cross-contamination. The production and application of hypochlorous acid, proven to protect against COVID-19, is quickly, simply and effectively creating a healthier environment and helping care homes and other health facilities to protect people.”
Salvesan has been formulated using Aqualution’s own technology which was invented by its team of British scientists with a pharmaceuticals background. Available as a surface disinfectant, deodouriser, hand sanitiser and soft furnishing disinfectant, the product can also be applied via an approved fogging system for rapid air and environmental sanitation to supplement the physical disinfection with the product.
The Aqualution technology generates HOCl, the chemical produced by the human immune system to fight infection. The unique electro-dialysis process which was designed in-house, produces a stable, fast-acting biocide with many different uses, and, it is environmentally-friendly and completely skin-safe.
Professor Clive Bowman, ex-medical director, consultant physician, gerontologist, and visiting professor at City University London, has undertaken research with the Salvesan team and has been involved in its successful implementation with several care providers. He said: “Salvesan is used in our routine approach to hygiene at several large providers due to it being proven for infection control. Thorough cleaning with detergent followed by disinfection with hypochlorous solution (Salvesan) using individual cloths for individual rooms/areas is simple, practical, affordable, safe and highly effective insofar as hypochlorous unlike most disinfectants is non-toxic to humans.
“Good hygiene control during Covid-19 is vital, particularly in a setting where we are looking after vulnerable elderly people who will cough more frequently than young healthy people, and use their hands to grasp surfaces to help them walk and move around.
“Surface cleaning in such environments is absolutely critical, and we must be able to confidently rely on disinfecting products that are safe when used liberally on a regular basis.”
Many care homes are now using the highly effective Salvesan product and demonstrating strong results. The business is experiencing exponential growth as a result of Covid-19 and to keep up with demand, the business has opened a new facility in Coldstream, in the Scottish Borders, ten miles south of its primary manufacturing facility in Duns. The second unit has enabled the business to increase production by 350% to fulfil bulk orders and to satisfy international demand from Europe, the Middle East, China, Africa and Canada.
Aqualution’s products are already widely used effectively in many other sectors such as the food supply chain, including those supplying M&S, Waitrose and Sainsbury’s; in the pet care and veterinary sector; and around 10% of UK dentists (this has doubled in recent weeks as dentists seek to enhance infection control to enable practices to re-open).
Aqualution Systems is the dossier holder for the approved active substance dossiers for the use of hypochlorous acid as a disinfectant under the Biocidal Products Regulation EU 528/2012 which is the European legislation that controls the registration and approvals for biocides.
The efficacy of the products has been validated by the European Chemicals agency and tested to rigorous internationally recognised standards, and comply with
BS EN 1276, BS EN 13704, BS EN 1656, BS EN 14204, BS EN 14476 and BS EN 1500.
The company has also been involved in a number of NHS projects and work with leading aged care providers in application science, leading to a number of papers demonstrating the effectiveness of the product in healthcare infection control, in “real world” applications, as well as in the laboratory.
About Aqualution Systems
Aqualution Systems was set up in 2002 by a team of scientists in the pharmaceutical industry with a strong commitment to solving real-world problems and making a real difference. Today, the business is striving to lead change in the hypochlorous acid revolution. Its biocide products represent a new era in health and hygiene that harnesses HOCl, a highly effective, weak acid that is naturally present in the human immune system.
Find out more at https://www.aqualution.co.uk/